CD226: An Emerging Role in Immunologic Diseases
Authors:
Open Access
- 24 July 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 8, 564
Abstract
CD226, a member of the immunoglobulin superfamily, is a functional protein initially expressed on natural killer and T cells. In recent years, the function of CD226 has been increasingly realized and researched. Accumulating evidence shows that CD226 is closely related to the occurrence of autoimmune diseases, infectious diseases, and tumors. Because of the CD226’s increasing importance, the author herein discusses the structure, mechanism of action, and role of CD226 in various pathophysiological environments, allowing for further understanding of the function of CD226 and providing the basis for further research in related diseases.Keywords
Funding Information
- National Institutes of Health
This publication has 106 references indexed in Scilit:
- A multicenter study confirms CD226gene association with systemic sclerosis-related pulmonary fibrosisArthritis Research & Therapy, 2012
- The TIGIT/CD226 Axis Regulates Human T Cell FunctionThe Journal of Immunology, 2012
- Interferon α–Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1The Journal of Infectious Diseases, 2012
- Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cellsEuropean Journal of Immunology, 2011
- Involvement of CD226+ NK Cells in Immunopathogenesis of Systemic Lupus ErythematosusThe Journal of Immunology, 2011
- Loss of DNAM‐1 contributes to CD8+ T‐cell exhaustion in chronic HIV‐1 infectionEuropean Journal of Immunology, 2010
- NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivoJournal of Clinical Investigation, 2009
- Shared and Distinct Genetic Variants in Type 1 Diabetes and Celiac DiseaseNew England Journal of Medicine, 2008
- DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumorsJournal of Experimental Medicine, 2008
- Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetesNature Genetics, 2007